According to this latest study, the 2021 growth of Hospital-Acquired Infection (HAI) Diagnostic will have significant change from previous year. By the most conservative estimates of global Hospital-Acquired Infection (HAI) Diagnostic market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Hospital-Acquired Infection (HAI) Diagnostic market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Hospital-Acquired Infection (HAI) Diagnostic market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Molecular Diagnostics
Blood Tests
Urinalysis
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Urinary Tract Infections
Pneumonia
Surgical Site Infections
Bloodstream Infections
Other Hospital Infections
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
bioM?rieux
Abbott Laboratories
Alere, Inc.
Roche
Siemens Healthcare
Becton Dickenson
Cepheid Inc.
Thermo Fisher Scientific
Seegene, Inc.
Qiagen
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size 2016-2026
2.1.2 Hospital-Acquired Infection (HAI) Diagnostic Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Hospital-Acquired Infection (HAI) Diagnostic Segment by Type
2.2.1 Molecular Diagnostics
2.2.2 Molecular Diagnostics
2.2.3 Urinalysis
2.3 Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type
2.3.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size CAGR by Type
2.3.2 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type (2016-2021)
2.4 Hospital-Acquired Infection (HAI) Diagnostic Segment by Application
2.4.1 Urinary Tract Infections
2.4.2 Pneumonia
2.4.3 Surgical Site Infections
2.4.4 Bloodstream Infections
2.4.5 Other Hospital Infections
2.5 Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application
2.5.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size CAGR by Application
2.5.2 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application (2016-2021)
3 Hospital-Acquired Infection (HAI) Diagnostic Market Size by Players
3.1 Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Players
3.1.1 Global Hospital-Acquired Infection (HAI) Diagnostic Revenue by Players (2019-2021E)
3.1.2 Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share by Players (2019-2021E)
3.2 Global Hospital-Acquired Infection (HAI) Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Hospital-Acquired Infection (HAI) Diagnostic by Regions
4.1 Hospital-Acquired Infection (HAI) Diagnostic Market Size by Regions (2016-2021)
4.2 Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth (2016-2021)
4.3 APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth (2016-2021)
4.4 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth (2016-2021)
4.5 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth (2016-2021)
5 Americas
5.1 Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021)
5.2 Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021)
5.3 Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size by Region (2016-2021)
6.2 APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021)
6.3 APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Hospital-Acquired Infection (HAI) Diagnostic by Country (2016-2021)
7.2 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021)
7.3 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic by Region (2016-2021)
8.2 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021)
8.3 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.1 Global Hospital-Acquired Infection (HAI) Diagnostic Forecast by Regions (2021-2026)
10.1.1 Global Hospital-Acquired Infection (HAI) Diagnostic Forecast by Regions (2021-2026)
10.1.2 Americas Hospital-Acquired Infection (HAI) Diagnostic Forecast
10.1.3 APAC Hospital-Acquired Infection (HAI) Diagnostic Forecast
10.1.4 Europe Hospital-Acquired Infection (HAI) Diagnostic Forecast
10.1.5 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Forecast
10.2 Americas Hospital-Acquired Infection (HAI) Diagnostic Forecast by Countries (2021-2026)
10.2.1 United States Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.2.2 Canada Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.2.3 Mexico Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.2.4 Brazil Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.3 APAC Hospital-Acquired Infection (HAI) Diagnostic Forecast by Region (2021-2026)
10.3.1 China Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.3.2 Japan Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.3.3 Korea Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.3.4 Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.3.5 India Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.3.6 Australia Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.4 Europe Hospital-Acquired Infection (HAI) Diagnostic Forecast by Country (2021-2026)
10.4.1 Germany Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.4.2 France Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.4.3 UK Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.4.4 Italy Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.4.5 Russia Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.5 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Forecast by Region (2021-2026)
10.5.1 Egypt Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.5.2 South Africa Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.5.3 Israel Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.5.4 Turkey Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.5.5 GCC Countries Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
10.6 Global Hospital-Acquired Infection (HAI) Diagnostic Forecast by Type (2021-2026)
10.7 Global Hospital-Acquired Infection (HAI) Diagnostic Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 bioM